European Patent Office

G 0001/98 (Transgenic plant/NOVARTIS II) of 20.12.1999

European Case Law Identifier
ECLI:EP:BA:1999:G000198.19991220
Date of decision
20 December 1999
Case number
G 0001/98
Petition for review of
T 1054/96 1997-10-13
Application number
91810144.5
IPC class
A01N 63/00
Language of proceedings
English
Distribution
Published in the EPO's Official Journal (A)
Other decisions for this case
-
Abstracts for this decision
-
Application title
Anti-pathogenically effective compositions comprising lytic peptides and hydrolytic enzymes
Applicant name
Novartis AG
Opponent name
-
Board
-
Headnote

I. A claim wherein specific plant varieties are not individually claimed is not excluded from patentability under Article 53(b), EPC even though it may embrace plant varieties.

II. When a claim to a process for the production of a plant variety is examined, Article 64(2) EPC is not to be taken into consideration.

III. The exception to patentability in Article 53(b), 1st half-sentence, EPC applies to plant varieties irrespective of the way in which they were produced. Therefore, plant varieties containing genes introduced into an ancestral plant by recombinant gene technology are excluded from patentability.

Keywords
Claims comprising but not identifying plant varieties
Plant varieties as products of recombinant gene technology
Article 64(2) EPC not relevant for examination of product claims
Catchword
-

ORDER

For these reasons it is decided that:

The questions of law referred to the Enlarged Board of Appeal are answered as follows:

1. See answers to questions 2 to 4.

2. A claim wherein specific plant varieties are not individually claimed is not excluded from patentability under Article 53(b) EPC, even though it may embrace plant varieties.

3. When a claim to a process for the production of a plant variety is examined, Article 64(2) EPC is not to be taken into consideration.

4. The exception to patentability in Article 53(b), 1st half-sentence, EPC applies to plant varieties irrespective of the way in which they were produced. Therefore, plant varieties containing genes introduced into an ancestral plant by recombinant gene technology are excluded from patentability.